Heather Turner
2011 - Orexigen Therapeutics
In 2011, Heather Turner earned a total compensation of $2.3M as Senior Vice President, General Counsel and Secretary at Orexigen Therapeutics, a 94% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $259,000 |
|---|---|
| Option Awards | $1,655,823 |
| Salary | $370,000 |
| Other | $7,458 |
| Total | $2,292,281 |
Turner received $1.7M in option awards, accounting for 72% of the total pay in 2011.
Turner also received $259K in non-equity incentive plan, $370K in salary and $7.5K in other compensation.
Rankings
In 2011, Heather Turner's compensation ranked 2,862nd out of 10,747 executives tracked by ExecPay. In other words, Turner earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,862 out of 10,747 | 73rd |
Division Manufacturing | 1,000 out of 3,960 | 75th |
Major group Chemicals And Allied Products | 201 out of 1,038 | 81st |
Industry group Drugs | 111 out of 786 | 86th |
Industry Pharmaceutical Preparations | 94 out of 571 | 84th |
Source: SEC filing on April 30, 2014.
Turner's colleagues
We found five more compensation records of executives who worked with Heather Turner at Orexigen Therapeutics in 2011.
2011
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2011
Preston Klassen
Orexigen Therapeutics
Head of Global NB32 Program and Senior Vice President, Product Development
2011
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2011
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2011
Graham Cooper
Orexigen Therapeutics